ArticleBMC medical ethics2026
Activities of national bioethics committees during the COVID-19 pandemic: publication trends and future challenges.
Article in BMC medical ethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionNational bioethics committees (NBCs) are expected to play a crucial role in addressing bioethical challenges. However, few studies have examined the activities of NBCs during the COVID-19 pandemic. This study investigated whether, and to what extent, NBCs were active during this public health emergency.
methodsBetween June and November 2024, we compiled and analyzed statements, opinions, guidelines, and reports on the COVID-19 pandemic issued by NBCs in Organisation for Economic Co-operation and Development countries, the Council of Europe, and Singapore. We collected online publications related to COVID-19 from these committees, starting in 2019, and categorized them based on their publication date and themes. As the authors are proficient only in Japanese and English, publications in languages other than English were reviewed with the assistance of ChatGPT.
resultsThe study examined 43 NBCs established in 35 countries and one organization. Among them, 22 committees-based in 21 countries and one organization-published materials on ethical issues related to the COVID-19 pandemic. In total, these 22 NBCs issued 108 publications. We categorized the publications into 10 groups, with the three most frequently addressed topics being "vaccination (including vaccine distribution)," "frameworks for COVID-19 policies," and "medical resource allocation." DISCUSSION: The results indicate that publications were issued promptly in response to the evolving crisis and addressed a broad spectrum of bioethical concerns. This study also identifies three challenges and areas for growth. First, when responding to urgent public health crises, NBCs must account for three key considerations: (1) the transparency of the statement publication process, (2) the incorporation of statements into public policies, and (3) protections for the persons involved in drafting such statements. Second, significant regional disparities exist in NBC activity levels. Finally, the findings underscore the need for a more coordinated and globally inclusive approach to bioethical governance in future public health emergencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.